Funded Tech Companies
Laverock Therapeutics
Headquartered in Stevenage, Laverock Therapeutics has funding from Eli Lilly and Company, Tekfen Ventures and Mercia Ventures.
Company Overview
Company Name
Laverock Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Incubator Building, Stevenage Bioscience Catalyst, Gunnels
Stevenage, SG1 2FX
UK
Stevenage, SG1 2FX
UK
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Laverock was founded around the core Gene Editing induced Gene Silencing Platform -- a step-change in RNAi technology. We fundamentally believe it unlocks the development of next-generation therapeutics through its unique and differentiated properties. We are actively developing a pipeline of GEiGS enabled ex vivo cell therapies, as well in vivo therapeutic approaches.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/28/2023
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Venables
Chief Financial Officer
Sandy McDougall
Chief Operating Officer
Tom Payne
Chief Scientific Officer
Vlad Seitan
Chief Technical Officer
Tim Allsopp
Company Investors
- Eli Lilly and Company
- Tekfen Ventures
- Mercia Ventures
- UK Innovation & Science Seed Fund
- Calculus Capital
- Maven Capital
- Eos Advisory
Browse more funded tech companies:
Share this article
About Our Venture Capital Transactions Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs